Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data.
about
Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status.Efficiency perspectives on adaptive designs in stroke clinical trials.Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trialsClinical pharmacological issues in the development of acute stroke therapies.Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE)Statistical power in quantitative diffusion MRI of tumor response: strategies for future studiesAdvanced MR techniques in multicenter clinical trials.Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control.Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.Stroke Lesions in a Large Upper Limb Rehabilitation Trial Cohort Rarely Match Lesions in Common Preclinical Models.Intravenous autologous bone marrow mononuclear cells for ischemic stroke.Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation.Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke.Hyperglycemia and the Fate of Apparent Diffusion Coefficient–Defined Ischemic Penumbra
P2860
Q34545798-7DB43E14-C0BC-41B5-9C50-1E2EC1099F3FQ35243020-3FF0EF8F-09AA-44EF-84FA-A885E8A36E23Q35268048-A92C7908-BC8C-4134-96A8-6ED4170CA6D9Q36496990-455C3568-9454-497C-A5E1-1B5CF1F1968AQ37222956-CEE42B16-340C-40EB-9952-000EF3FFCC60Q37252669-1BEA2A27-8ED9-4954-993E-5E98CA153511Q37969383-AD6A3F68-5838-4232-B7C5-48CFFE631CD4Q38092796-B93B5417-5BD5-4957-A833-1EDADF2458EDQ38459886-17747A4C-A74F-4B91-BFA3-5E6B4A40AE69Q40031757-981F13B2-E882-40D6-B336-C70BE7F64126Q46451675-A6F4A4CE-ADEB-498D-B85A-A9093D010950Q49015926-EF4503FE-9FD3-48AF-AAE4-FB878315E77FQ51039938-8E602AA8-53A4-4761-8BF6-C0C65D68BCCBQ55311934-AB783343-1CFE-4934-BE4B-7E30B30D8FB9Q57700542-B01D4376-C027-42A9-AC1E-436DCEC48D5F
P2860
Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Proof-of-principle phase II MR ...... chotomous and continuous data.
@ast
Proof-of-principle phase II MR ...... chotomous and continuous data.
@en
type
label
Proof-of-principle phase II MR ...... chotomous and continuous data.
@ast
Proof-of-principle phase II MR ...... chotomous and continuous data.
@en
prefLabel
Proof-of-principle phase II MR ...... chotomous and continuous data.
@ast
Proof-of-principle phase II MR ...... chotomous and continuous data.
@en
P2093
P1433
P1476
Proof-of-principle phase II MR ...... ichotomous and continuous data
@en
P2093
MR Stroke Collaborative Group
Stephen M Davis
Thanh G Phan
P304
P356
10.1161/01.STR.0000239696.61545.4B
P407
P577
2006-08-24T00:00:00Z